134 related articles for article (PubMed ID: 38019650)
1. IL-18-induced HIF-1α in ILC3s ameliorates the inflammation of C. rodentium-induced colitis.
Valle-Noguera A; Sancho-Temiño L; Castillo-González R; Villa-Gómez C; Gomez-Sánchez MJ; Ochoa-Ramos A; Yagüe-Fernández P; Soler Palacios B; Zorita V; Raposo-Ponce B; González-Granado JM; Aragonés J; Cruz-Adalia A
Cell Rep; 2023 Dec; 42(12):113508. PubMed ID: 38019650
[TBL] [Abstract][Full Text] [Related]
2. Epithelial-intrinsic IKKα expression regulates group 3 innate lymphoid cell responses and antibacterial immunity.
Giacomin PR; Moy RH; Noti M; Osborne LC; Siracusa MC; Alenghat T; Liu B; McCorkell KA; Troy AE; Rak GD; Hu Y; May MJ; Ma HL; Fouser LA; Sonnenberg GF; Artis D
J Exp Med; 2015 Sep; 212(10):1513-28. PubMed ID: 26371187
[TBL] [Abstract][Full Text] [Related]
3. Ornithine decarboxylase supports ILC3 responses in infectious and autoimmune colitis through positive regulation of IL-22 transcription.
Peng V; Cao S; Trsan T; Bando JK; Avila-Pacheco J; Cleveland JL; Clish C; Xavier RJ; Colonna M
Proc Natl Acad Sci U S A; 2022 Nov; 119(45):e2214900119. PubMed ID: 36279426
[TBL] [Abstract][Full Text] [Related]
4. Induction of innate lymphoid cell-derived interleukin-22 by the transcription factor STAT3 mediates protection against intestinal infection.
Guo X; Qiu J; Tu T; Yang X; Deng L; Anders RA; Zhou L; Fu YX
Immunity; 2014 Jan; 40(1):25-39. PubMed ID: 24412612
[TBL] [Abstract][Full Text] [Related]
5. Unique and redundant functions of NKp46+ ILC3s in models of intestinal inflammation.
Song C; Lee JS; Gilfillan S; Robinette ML; Newberry RD; Stappenbeck TS; Mack M; Cella M; Colonna M
J Exp Med; 2015 Oct; 212(11):1869-82. PubMed ID: 26458769
[TBL] [Abstract][Full Text] [Related]
6. ILC3s integrate glycolysis and mitochondrial production of reactive oxygen species to fulfill activation demands.
Di Luccia B; Gilfillan S; Cella M; Colonna M; Huang SC
J Exp Med; 2019 Oct; 216(10):2231-2241. PubMed ID: 31296736
[TBL] [Abstract][Full Text] [Related]
7. HMGB1 exacerbates experimental mouse colitis by enhancing innate lymphoid cells 3 inflammatory responses via promoted IL-23 production.
Chen X; Li L; Khan MN; Shi L; Wang Z; Zheng F; Gong F; Fang M
Innate Immun; 2016 Nov; 22(8):696-705. PubMed ID: 27670944
[TBL] [Abstract][Full Text] [Related]
8. Lymphotoxin controls the IL-22 protection pathway in gut innate lymphoid cells during mucosal pathogen challenge.
Tumanov AV; Koroleva EP; Guo X; Wang Y; Kruglov A; Nedospasov S; Fu YX
Cell Host Microbe; 2011 Jul; 10(1):44-53. PubMed ID: 21767811
[TBL] [Abstract][Full Text] [Related]
9. Role of Nutrient-sensing Receptor GPRC6A in Regulating Colonic Group 3 Innate Lymphoid Cells and Inflamed Mucosal Healing.
Hou Q; Huang J; Xiong X; Guo Y; Zhang B
J Crohns Colitis; 2022 Aug; 16(8):1293-1305. PubMed ID: 35134872
[TBL] [Abstract][Full Text] [Related]
10. Macrophage β2-Integrins Regulate IL-22 by ILC3s and Protect from Lethal Citrobacter rodentium-Induced Colitis.
Wang B; Lim JH; Kajikawa T; Li X; Vallance BA; Moutsopoulos NM; Chavakis T; Hajishengallis G
Cell Rep; 2019 Feb; 26(6):1614-1626.e5. PubMed ID: 30726742
[TBL] [Abstract][Full Text] [Related]
11. Gata3 drives development of RORγt+ group 3 innate lymphoid cells.
Serafini N; Klein Wolterink RG; Satoh-Takayama N; Xu W; Vosshenrich CA; Hendriks RW; Di Santo JP
J Exp Med; 2014 Feb; 211(2):199-208. PubMed ID: 24419270
[TBL] [Abstract][Full Text] [Related]
12. IL-21 Controls ILC3 Cytokine Production and Promotes a Protective Phenotype in a Mouse Model of Colitis.
Poholek CH; Dulson SJ; Zajac AJ; Harrington LE
Immunohorizons; 2019 Jun; 3(6):194-202. PubMed ID: 31356165
[TBL] [Abstract][Full Text] [Related]
13. Retinoid orphan receptor gamma t (rorγt) promotes inflammatory eosinophilia but is dispensable for innate immune-mediated colitis.
Torres-Huerta A; Ruley-Haase K; Reed T; Boger-May A; Rubadeux D; Mayer L; Rajashekara AM; Hiller M; Frech M; Roncagli C; Pedersen C; Camacho MC; Hollmer L; English L; Kane G; Boone DL
PLoS One; 2024; 19(3):e0300892. PubMed ID: 38512959
[TBL] [Abstract][Full Text] [Related]
14. Trained ILC3 responses promote intestinal defense.
Serafini N; Jarade A; Surace L; Goncalves P; Sismeiro O; Varet H; Legendre R; Coppee JY; Disson O; Durum SK; Frankel G; Di Santo JP
Science; 2022 Feb; 375(6583):859-863. PubMed ID: 35201883
[TBL] [Abstract][Full Text] [Related]
15. Bcl6 is a subset-defining transcription factor of lymphoid tissue inducer-like ILC3.
Tachó-Piñot R; Stamper CT; King JI; Matei-Rascu V; Richardson E; Li Z; Roberts LB; Bassett JW; Melo-Gonzalez F; Fiancette R; Lin IH; Dent A; Harada Y; Finlay C; Mjösberg J; Withers DR; Hepworth MR
Cell Rep; 2023 Nov; 42(11):113425. PubMed ID: 37950867
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity and diversity of group 3 innate lymphoid cells: new cells on the block.
Satoh-Takayama N
Int Immunol; 2016 Jan; 28(1):29-34. PubMed ID: 26462712
[TBL] [Abstract][Full Text] [Related]
17. Group 3 innate lymphoid cells (ILC3s): Origin, differentiation, and plasticity in humans and mice.
Montaldo E; Juelke K; Romagnani C
Eur J Immunol; 2015 Aug; 45(8):2171-82. PubMed ID: 26031799
[TBL] [Abstract][Full Text] [Related]
18. Human RORγt(+)CD34(+) cells are lineage-specified progenitors of group 3 RORγt(+) innate lymphoid cells.
Montaldo E; Teixeira-Alves LG; Glatzer T; Durek P; Stervbo U; Hamann W; Babic M; Paclik D; Stölzel K; Gröne J; Lozza L; Juelke K; Matzmohr N; Loiacono F; Petronelli F; Huntington ND; Moretta L; Mingari MC; Romagnani C
Immunity; 2014 Dec; 41(6):988-1000. PubMed ID: 25500367
[TBL] [Abstract][Full Text] [Related]
19. Circadian rhythm-dependent and circadian rhythm-independent impacts of the molecular clock on type 3 innate lymphoid cells.
Wang Q; Robinette ML; Billon C; Collins PL; Bando JK; Fachi JL; Sécca C; Porter SI; Saini A; Gilfillan S; Solt LA; Musiek ES; Oltz EM; Burris TP; Colonna M
Sci Immunol; 2019 Oct; 4(40):. PubMed ID: 31586012
[TBL] [Abstract][Full Text] [Related]
20. The chemokine receptor CXCR6 controls the functional topography of interleukin-22 producing intestinal innate lymphoid cells.
Satoh-Takayama N; Serafini N; Verrier T; Rekiki A; Renauld JC; Frankel G; Di Santo JP
Immunity; 2014 Nov; 41(5):776-88. PubMed ID: 25456160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
